ClinicalTrials.gg
CompletedNCT07897643NFF-BFUpdated Oct 27, 2026

Effects of Nurse-Led Finger Feeding Support on Breastfeeding Self-Efficacy and Early Breastfeeding Outcomes

An interventional study of Nurse-Led Finger Feeding Education and Support in Breastfeeding Self-Efficacy and Breastfeeding Outcomes, sponsored by Harran University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Harran University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Oct 2026).
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Enrollment
94th of 252
90 · median 80
Started
2026
with 32 others
No phase
251 of 274
65 open now
Registered
270th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 94th largest by enrollment of the 252 interventional ones, is one of 33 that started in 2026, is one of 251 with no phase, and was the 270th registered.

By phase

274 studies; the count open now beside each. This study's row is marked.

No phasethis study251 · 65 open
Observational22 · 3 open
Phase 41 · 0 open

By the year they started

First in 2011; this study’s year is marked. 33 started in 2026.

What they test

Size and results

Median enrollment 80 across the 252 interventional studies, 163 across the 22 observational. Of the 178 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

Breast milk is the most suitable source of nutrition for a newborn's growth and development and provides significant benefits for both maternal and infant health. However, in the early postpartum period, some mothers and infants may experience difficulties with breastfeeding, which can negatively affect the initiation and continuation of breastfeeding. Difficulties encountered during breastfeeding can undermine a mother's confidence in her ability to breastfeed and negatively affect breastfeeding success. Therefore, it is important to develop nursing interventions aimed at supporting breastfeeding. Finger-feeding is one of the alternative feeding methods used to support sucking skills and is thought to be beneficial in supporting the breastfeeding process.

This study was designed as a randomized controlled experimental study to determine the effect of nurse-led finger-feeding support on mothers' breastfeeding self-efficacy and early-stage breastfeeding outcomes.

03

Conditions studied

  • Breastfeeding Self-Efficacy
  • Breastfeeding Outcomes

Browse trials for

Keywords

  • Finger Feeding
  • Breastfeeding Self-Efficacy
  • Nurse-Led Intervention
  • Breastfeeding Support
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mothers aged 18 years or older.
  • Mothers in the early postpartum period.
  • Mothers who have a term newborn.
  • Mothers whose newborns experience difficulty initiating breastfeeding or latching onto the breast.
  • Mothers who are able to read, write, and speak Turkish without difficulty.
  • Mothers who voluntarily agree to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Mothers whose newborns have congenital anomalies.
  • Mothers whose newborns are admitted to or monitored in a neonatal intensive care unit.
  • Mothers with a medical condition that contraindicates feeding their infant breast milk.
  • Mothers with serious health problems that prevent breastfeeding.
  • Mothers who are unwilling to participate in the study follow-up process.

The inclusion and exclusion criteria are identical for the intervention and control groups.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Nurse-Led Finger Feeding Support Group

    Mothers assigned to the intervention group will receive nurse-led finger feeding education and support in addition to standard breastfeeding counseling. The intervention will be delivered individually before hospital discharge and will include information about the purpose, procedure, precautions, and steps of finger feeding, followed by a practical demonstration and guidance as needed.

    Behavioral: Nurse-Led Finger Feeding Education and Support

  • No intervention
    Standard Breastfeeding Counseling Group

    Mothers assigned to the control group will receive standard breastfeeding counseling routinely provided at the hospital. No additional finger feeding education or support will be provided as part of the study intervention.

Interventions

  • BehavioralNurse-Led Finger Feeding Education and Support

    The intervention consists of individualized nurse-led finger feeding education and support provided during the postpartum hospital stay before discharge. Mothers will receive information on the purpose, technique, precautions, and procedural steps of finger feeding. The researcher will demonstrate the technique and provide practical guidance when needed. All participants will also receive standard breastfeeding counseling.

06

What researchers measure

Primary outcomes

  1. Change in Breastfeeding Self-Efficacy Score

    Breastfeeding self-efficacy will be assessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), consisting of 14 items scored on a five-point Likert scale. Total scores range from 14 to 70, with higher scores indicating greater breastfeeding self-efficacy. Changes in scores over time will be compared between the intervention and control groups.

    Time frame: Baseline (before intervention), within 24 hours postpartum (after intervention), and 1 month postpartum

  2. Change in LATCH Breastfeeding Assessment Score

    Breastfeeding performance will be assessed using the LATCH Breastfeeding Assessment Tool, which evaluates five components: latch, audible swallowing, type of nipple, breast/nipple comfort, and positioning assistance. Each component is scored from 0 to 2, yielding a total score ranging from 0 to 10. Higher scores indicate better breastfeeding performance. Changes in LATCH scores from baseline to before hospital discharge will be compared between the intervention and control groups.

    Time frame: Baseline (before intervention) and within 24 hours postpartum (after intervention)

Secondary outcomes

  1. Exclusive Breastfeeding Status at 1 Month Postpartum

    Exclusive breastfeeding status will be assessed through a telephone interview at 1 month postpartum. Mothers will report whether their infants are receiving breast milk only, without formula or other foods or liquids, except medications, vitamins, or oral rehydration solutions. The proportion of infants exclusively breastfed will be compared between groups.

    Time frame: 1 month postpartum

  2. Formula Feeding Status at 1 Month Postpartum

    Formula feeding status will be assessed through a telephone interview at 1 month postpartum. Mothers will report whether their infants are receiving infant formula, either alone or in combination with breast milk. The proportion of infants receiving formula will be compared between groups.

    Time frame: 1 month postpartum

  3. Breastfeeding Continuation at 1 Month Postpartum

    Breastfeeding continuation will be assessed through a telephone interview at 1 month postpartum. Mothers will report whether they are continuing to breastfeed their infants, either exclusively or in combination with formula feeding. The proportion of mothers continuing any breastfeeding will be compared between groups.

    Time frame: 1 month postpartum

  4. Occurrence of Breastfeeding Problems at 1 Month Postpartum

    Breastfeeding problems will be assessed through a telephone interview at 1 month postpartum. Mothers will report whether they have experienced any breastfeeding-related difficulties. The proportion of mothers reporting at least one breastfeeding problem will be compared between the intervention and control groups.

    Time frame: 1 month postpartum

07

Study locations

1 site
  • Manisa Celal Bayar University Hafsa Sultan Hospital
    Manisa, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because no data-sharing plan has been established for this study. Study findings will be reported in aggregate form without identifying individual participants.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Aug 2026, 1 month.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 1 month is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2026
First posted
Oct 27, 2026
StartActual
Jul 10, 2026
Primary completionActual
Aug 10, 2026
CompletionActual
Oct 15, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07897643
Lead sponsor
Harran University
Responsible party
HASRET YAĞMUR SEVİNÇ AKIN (Assistant Professor, Harran University) — Principal investigator
First posted
Oct 27, 2026
Start date
Jul 10, 2026
Primary completion
Aug 10, 2026
Completion
Oct 15, 2026
Last update
Oct 27, 2026

Study contacts

H YAĞMUR SEVİNÇ, Assistant Professor
principal investigator · Harran University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion